Morgan Stanley cuts India's GlaxoSmithKline Pharma to 'under-weight' | business | Hindustan Times
Today in New Delhi, India
Jan 23, 2017-Monday
-°C
New Delhi
  • Humidity
    -
  • Wind
    -

Morgan Stanley cuts India's GlaxoSmithKline Pharma to 'under-weight'

business Updated: Feb 28, 2013 10:25 IST
Reuters
Highlight Story

Morgan Stanley cut its rating on India's GlaxoSmithKline Pharmaceuticals Ltd to "under-weight" from "equal-weight", citing expectations the drug maker will post modest growth and saying margin expansion looked unlikely.

GlaxoSmithKline's shares are also constrained by its pricing policy and "full" valuations, the broker added.